GlaxoSmithKline LLC v. Louisiana
139 S. Ct. 659, 202 L. Ed. 2d 509
CourtSupreme Court of the United States
DecidedDecember 18, 2018
DocketNo. 18–42 (R46–05/OT 2018).
StatusPublished
This text of 139 S. Ct. 659 (GlaxoSmithKline LLC v. Louisiana) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
GlaxoSmithKline LLC v. Louisiana, 139 S. Ct. 659, 202 L. Ed. 2d 509 (U.S. 2018).
Opinion
The petition for writ of certiorari was dismissed today pursuant to Rule 46.1 of the Rules of this Court.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
139 S. Ct. 659, 202 L. Ed. 2d 509, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glaxosmithkline-llc-v-louisiana-scotus-2018.